Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2530 to 2579 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2530\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 8 precursor (ec 3.4.25.1) (proteasome component c13) (macropain subunit c13) (multicatalytic endopeptidase complex subunit c13). [source:swissprot;acc:p28062]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.464\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00224\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2531\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apurinic/apyrimidinic endonuclease 2; apurinic/apyrimidinic endonuclease-like 2; apex nuclease-like 2. [source:refseq;acc:nm\_014481]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.264\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.787\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00221\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2532\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
54 kda nuclear rna- and dna-binding protein (p54(nrb)) (p54nrb) (55 kda nuclear protein) (nmt55) (non-pou domain-containing octamer- binding protein) (dna-binding p52/p100 complex, 52 kda subunit). [source:swissprot;acc:q15233]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
190.405\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.812\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00214\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2533\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
paraspeckle protein 1. [source:refseq;acc:nm\_018282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
190.417\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.824\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol-3-phosphate dehydrogenase, mitochondrial precursor (ec 1.1.99.5) (gpd-m) (gpdh-m). [source:swissprot;acc:p43304]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.555\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2535\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 1 (heterochromatin protein 1 homolog beta) (hp1 beta) (modifier 1 protein) (m31) (heterochromatin protein p25). [source:swissprot;acc:p23197]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
188.228\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.63\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2536\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
geranylgeranyl pyrophosphate synthetase (ggpp synthetase) (ggppsase) (geranylgeranyl diphosphate synthase) [includes: dimethylallyltransferase (ec 2.5.1.1); geranyltranstransferase (ec 2.5.1.10); farnesyltranstransferase (ec 2.5.1.29)]. [source:swissprot;acc:o95749]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
236.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
236.008\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00213\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2537\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar protein sorting-associated protein 45 (h-vps45) (hlvps45). [source:swissprot;acc:q9nrw7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.964\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.421\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00212\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2538\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor, proline-and glutamine-rich (polypyrimidine tract- binding protein-associated splicing factor) (ptb-associated splicing factor) (psf) (dna-binding p52/p100 complex, 100 kda subunit). [source:swissprot;acc:p23246]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
190.765\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.163\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00209\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2539\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gc-rich sequence dna-binding factor homolog. [source:swissprot;acc:q9y5b6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.144\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.699\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00205\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2540\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
toll-like receptor 2 precursor (toll/interleukin 1 receptor-like protein 4). [source:swissprot;acc:o60603]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2541\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartyl-trna synthetase (ec 6.1.1.12) (aspartate--trna ligase) (asprs). [source:swissprot;acc:p14868]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
194.505\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.902\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00204\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2542\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p29ing4; candidate tumor suppressor p33 ing1 homolog. [source:refseq;acc:nm\_016162]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.068\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.633\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.002\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2543\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin tyrosine ligase-like protein hottl (hqp0207). [source:swissprot;acc:q9y4r7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.726\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00195\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2544\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aminomethyltransferase, mitochondrial precursor (ec 2.1.2.10) (glycine cleavage system t protein) (gcvt). [source:swissprot;acc:p48728]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.262\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00192\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2545\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 9 precursor (ec 3.4.25.1) (proteasome chain 7) (macropain chain 7) (multicatalytic endopeptidase complex chain 7) (ring12 protein) (low molecular mass protein 2). [source:swissprot;acc:p28065]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.494\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.088\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00191\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2546\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tbp-associated factor 9l; neuronal cell death-related protein; taf9-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 31 kd; neuronal cell death-related gene in neuron-7; transcription associated factor tafii31l; transcription initiation factor iid, 31kd subunit. [source:refseq;acc:nm\_015975]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
197.138\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
197.507\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00187\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2547\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol kinase, testis specific 2 (ec 2.7.1.30) (atp:glycerol 3- phosphotransferase) (glycerokinase) (gk). [source:swissprot;acc:q14410]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.894\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00186\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2548\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol kinase, testis specific 1 (ec 2.7.1.30) (atp:glycerol 3- phosphotransferase) (glycerokinase) (gk). [source:swissprot;acc:q14409]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.899\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.516\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00185\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2549\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol kinase (ec 2.7.1.30) (atp:glycerol 3-phosphotransferase) (glycerokinase) (gk). [source:swissprot;acc:p32189]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.902\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.519\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2550\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 2 isoform b; eps15 binding protein. [source:refseq;acc:nm\_014964]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.587\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.988\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2551\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.766\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.148\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00182\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2552\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific chromodomain y protein 1. [source:swissprot;acc:q9y6f8]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
193.12\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
193.467\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0018\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain protein, y chromosome-like isoform a; cdy-like, autosomal; testis-specific chromodomain y-like protein. [source:refseq;acc:nm\_004824]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2554\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific chromodomain protein y protein 2. [source:swissprot;acc:q9y6f7]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2555\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase gamma form (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-ii). [source:swissprot;acc:p31153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.953\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.572\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2556\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain y-like protein 2. [source:refseq;acc:nm\_152342]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
193.119\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00177\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2557\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 2 (ef-2). [source:swissprot;acc:p13639]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
222.658\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.047\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00175\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metabotropic glutamate receptor 2 precursor (mglur2). [source:swissprot;acc:q14416]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metabotropic glutamate receptor 3 precursor (mglur3). [source:swissprot;acc:q14832]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2560\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
monoglyceride lipase; lysophospholipase-like. [source:refseq;acc:nm\_007283]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.395\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.042\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2561\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase (ec 3.1.3.11) (d-fructose-1,6-bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:p09467]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.825\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00169\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2562\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogenin-1 (ec 2.4.1.186). [source:swissprot;acc:p46976]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
208.429\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
208.779\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00168\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2563\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenosine kinase (ec 2.7.1.20) (ak) (adenosine 5'-phosphotransferase). [source:swissprot;acc:p55263]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2564\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein x 0001. [source:refseq;acc:nm\_016302]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogenin-2 (ec 2.4.1.186) (gn-2) (gn2). [source:swissprot;acc:o15488]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2566\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein kinase 12 (ec 2.7.1.37) (aurora- and ipl1- like midbody-associated protein 1) (aim-1) (aurora/ipl1-related kinase 2) (aurora-related kinase 2) (stk-1) (aurora-b). [source:swissprot;acc:q96gd4]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.907\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.267\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00164\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2567\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif23 (mitotic kinesin-like protein-1) (kinesin- like protein 5). [source:swissprot;acc:q02241]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2568\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein kinase 13 (ec 2.7.1.37) (aurora/ipl1/eg2 protein 2) (aurora/ipl1-related kinase 3) (aurora-c). [source:swissprot;acc:q9uqb9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2569\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine kinase 6 (ec 2.7.1.37) (serine/threonine kinase 15) (aurora/ipl1-related kinase 1) (aurora-related kinase 1) (hark1) (aurora-a) (breast-tumor-amplified kinase). [source:swissprot;acc:o14965]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2570\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cylindromatosis (turban tumor syndrome); cylindromatosis 1, turban tumor syndrome. [source:refseq;acc:nm\_015247]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 1 (ec 3.1.3.48) (protein-tyrosine phosphatase 1b) (ptp-1b). [source:swissprot;acc:p18031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.549\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.205\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 20/15 kda subunits (tafii- 20/tafii-15) (tafii20/tafii15). [source:swissprot;acc:q16514]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.953\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.285\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00163\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2573\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxiredoxin 4 (ec 1.11.1.-) (prx-iv) (thioredoxin peroxidase ao372) (thioredoxin-dependent peroxide reductase a0372) (antioxidant enzyme aoe372) (aoe37-2). [source:swissprot;acc:q13162]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.347\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.005\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00161\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2574\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf-related matrix-associated actin-dependent regulator of chromatin c1; mammalian chromatin remodeling complex brg1-associated factor 155; swi/snf complex 155 kda subunit; chromatin remodeling complex baf155 subunit. [source:refseq;acc:nm\_003074]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.016\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.667\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00159\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 2 (ec 3.1.3.48) (t- cell protein-tyrosine phosphatase) (tcptp). [source:swissprot;acc:p17706]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.583\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.255\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00157\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-1-syntrophin (59 kda dystrophin-associated protein a1, basic component 1) (dapa1b) (tax interaction protein 43) (tip-43) (syntrophin 2) (bsyn2). [source:swissprot;acc:q13884]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.422\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.75\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00154\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ca2+-dependent endoplasmic reticulum nucleoside diphosphatase; apyrase; soluble calcium-activated nucleotidase scan-1. [source:refseq;acc:nm\_138793]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
192.625\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.922\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2578\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-2-syntrophin (59 kda dystrophin-associated protein a1, basic component 2) (syntrophin 3) (snt3) (syntrophin-like) (sntl). [source:swissprot;acc:q13425]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
213.422\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.75\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2579\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nitrilase 1. [source:refseq;acc:nm\_005600]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/